Feed / MMED

MiniMed Group, Inc.

MMED

Healthcare · 20.48 +1.3% today

Isolated · not yet confirmedMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

MiniMed Group, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 8 directly disclosed connections are confirming.

Company+1.3% todayVolume comparison unavailable
Market group0 of 1 activeDiabetes Devices · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • MMED's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if MMED's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind MMED

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

MDTMedtronic plc.investeeJun 29, 2026

Historically, MiniMed operated as Medtronic plc’s (“Medtronic”) global diabetes business (the “Diabetes Business”).

ABTAbbott LaboratoriespartnerJun 29, 2026

On June 3, 2026, we announced an extension to our partnership with Abbott Laboratories, to commercialize dual glucose-ketone sensors designed to integrate exclusively with our MiniMed smart dosing systems.

Depended on by

MDTMedtronic plc.partnerNov 25, 2025

The increase in net sales was primarily driven by strong international growth due to the continued adoption of the MiniMed 780G AID system, including the Simplera Sync and Guardian 4 CGM sensors and Extended Infusion Sets, and the impacts of foreign currency…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

MMED is currently a Leader in the organic co-movement group Diabetes Devices. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for MMED; it is not active in the latest market snapshot.